The INSPIRED study: a randomised controlled trial of the Whole Person Model of disease self-management for people with type 2 diabetes

BMC Public Health

Helena J Teede¹  Virginia L Hagger²  Dinali N Perera³  Donita E Baird³  David M Clarke³ 

[1] Monash Centre for Health Research and Implementation, School of Public Health and Preventative Medicine, Monash University and Diabetes Unit, Monash Health, Melbourne, Australia;Diabetes Australia Victoria, Melbourne, Australia;Department of Psychological Medicine, Monash University and Monash Health, Level 3, P Block, Monash Medical Centre, 246 Clayton Rd, Clayton, 3168 Melbourne, VIC, Australia

关键词: Resources;    Support;    Depression;    Self-management;    Diabetes;    Type 2 diabetes mellitus;   

Others  :  1145383
DOI  :  10.1186/1471-2458-14-134

 received in 2014-01-20, accepted in 2014-01-27,  发布年份 2014

【 摘 要 】

Background

The prevalence of type 2 diabetes has increased dramatically in the last decade, and is continuing to rise. It is a chronic condition, often related to obesity, diet and sedentary lifestyles, and can lead to significant health complications, disability and early death. Diabetes is commonly associated with depression, which can impact significantly on a person’s ability to manage their illness and, consequently, on disease outcomes. Disease self-management is fundamental in diabetes and requires support from multiple health professionals and the active participation of the person, including in maintaining a healthy lifestyle. The Whole Person Model was developed in order to integrate emotional and behavioural aspects into a self-management program for people with type 2 diabetes. Here we describe a study designed to test the efficacy of the Whole Person Model of disease self-management in type 2 diabetes.

Methods/Design

In a parallel-group randomised trial, 180 people with type 2 diabetes of between 2–10 years duration will be recruited via invitation through the Australian National Diabetes Services Scheme. Participants will undergo baseline assessment, followed by randomisation to either intervention or control condition. Control participants will receive fact sheets containing key information about diabetes self-management. The intervention group will receive the INSPIRED (Individual Support & Resources for Diabetes) Manual and be assigned a Health Coach. The INSPIRED Manual consists of six modules that provide key information about diabetes and disease management using the Whole Person Model. Engagement is facilitated by interactive tasks and contact with a Health Coach over seven weeks – an introductory face-to-face session, and six subsequent contacts by phone following each module. Follow-up assessments occur at 13 weeks (post-intervention) and 26 weeks. Primary outcomes include blood glucose management (HbA_1c), weight and mood. Secondary outcomes include level of exercise, confidence to manage diabetes, and psychosocial well-being.

Discussion

The Whole Person Model is designed to enable health professionals to address mood disturbance without pathologizing any disorders and, in the context of the chronic illness, empowering behavior change and self-management. If proven effective, this model will strengthen capacity of the healthcare workforce to foster and support effective diabetes self-management.

Trial registration

Australia and New Zealand Clinical Trials Register, ACTRN12613000391774

【 授权许可】

   
2014 Clarke et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]World Health Organization: Diabetes Fact Sheet. No. 312. Geneva: World Health Organization; 2011.
• [2]Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27(5):1047-1053.
• [3]American Diabetes Association: Executive summary: standards of medical care in diabetes - 2010. Diabetes Care 2010, 33(Suppl 1):4-10.
• [4]Grinstein G, Muzumdar R, Aponte L, Vuguin P, Saenger P, DiMartino-Nardi J: Presentation and 5-year follow-up of type 2 diabetes mellitus in African-American and Caribbean-Hispanic adolescents. Horm Res Pediatr 2003, 60(3):121-126.
• [5]Haines L, Wan KC, Lynn R, Barrett TG, Shield JP: Rising incidence of type 2 diabetes in children in the UK. Diabetes Care 2007, 30(5):1097-1101.
• [6]Zhang Y, Dall TM, Mann SE, Chen Y, Martin J, Moore V, Baldwin A, Reidel VA, Quick WW: The economic costs of undiagnosed diabetes. Popul Health Manag 2009, 12(2):95-101.
• [7]Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, Connolly V, King H: The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 2005, 28(9):2130-2135.
• [8]Australian Insititute of Health and Welfare: Australia’s Health 2008. Canberra: AIHW; 2008.
• [9]Gavard JA, Lustman PJ, Clouse RE: Prevalence of depression in adults with diabetes: an epidemiological evaluation. Diabetes Care 1993, 16(8):1167-1178.
• [10]Peyrot M, Rubin RR: Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care 1997, 20(4):585-590.
• [11]Young BA, Von Korff M, Heckbert SR, Ludman EJ, Rutter C, Lin EH, Ciechanowski PS, Oliver M, Williams L, Himmelfarb J: Association of major depression and mortality in stage 5 diabetic chronic kidney disease. Gen Hosp Psychiatry 2010, 32(2):119-124.
• [12]Anderson RJ, Freedland KE, Clouse RE, Lustman PJ: The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001, 24(6):1069-1078.
• [13]Knol M, Twisk J, Beekman A, Heine R, Snoek F, Pouwer F: Depression as a risk factor for the onset of type 2 diabetes mellitus: a meta-analysis. Diabetologia 2006, 49(5):837-845.
• [14]Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, Zitman FG: Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010, 67(3):220.
• [15]Goodwin RD: Association between physical activity and mental disorders among adults in the United States. Prev Med 2003, 36(6):698-703.
• [16]Björntorp P: Do stress reactions cause abdominal obesity and comorbidities? Obes Rev 2001, 2(2):73-86.
• [17]Shoelson SE, Lee J, Goldfine AB: Inflammation and insulin resistance. J Clin Invest 2006, 116(7):1793-1801.
• [18]DiMatteo MR, Lepper HS, Croghan TW: Depression is a risk factor for noncompliance with medical treatmentmeta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000, 160(14):2101-2107.
• [19]Gonzalez JS, Safren SA, Cagliero E, Wexler DJ, Delahanty L, Wittenberg E, Blais MA, Meigs JB, Grant RW: Depression, self-care, and medication adherence in type 2 diabetes relationships across the full range of symptom severity. Diabetes Care 2007, 30(9):2222-2227.
• [20]Ali S, Stone M, Skinner TC, Robertson N, Davies M, Khunti K: The association between depression and health‒related quality of life in people with type 2 diabetes: a systematic literature review. Diabetes Metab Res Rev 2010, 26(2):75-89.
• [21]Ciechanowski PS, Katon WJ, Russo JE, Hirsch IB: The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry 2003, 25(4):246-252.
• [22]Wing RR, Phelan S, Tate D: The role of adherence in mediating the relationship between depression and health outcomes. J Psychosom Res 2002, 53(4):877-881.
• [23]Musselman DL, Betan E, Larsen H, Phillips LS: Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 2003, 54(3):317-329.
• [24]Lustman PJ, Clouse RE: Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complicat 2005, 19(2):113-122.
• [25]Egede LE, Nietert PJ, Zheng D: Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 2005, 28(6):1339-1345.
• [26]Gilmer TP, O’Connor PJ, Rush WA, Crain AL, Whitebird RR, Hanson AM, Solberg LI: Predictors of health care costs in adults with diabetes. Diabetes Care 2005, 28(1):59-64.
• [27]Funnell MM, Brown TL, Childs BP, Haas LB, Hosey GM, Jensen B, Maryniuk M, Peyrot M, Piette JD, Reader D, Siminerio LM, Weinger K, Weiss MA: National standards for diabetes self-management education. Diabetes Care 2008, 31(Supplement 1):S97-S104.
• [28]Jordan JE, Osborne RH: Chronic disease self-management education programs: challenges ahead. Med J Aust 2007, 186(2):84.
• [29]Anon: 2nd International DAWN Summit: a call-to-action to improve psychosocial care for people with diabetes. Pract Diab Int 2004, 21(5):201-208.
• [30]Baird D, Clarke D: The whole person model: a collaborative approach to chronic disease management. Health Issues 2011, 106:21-26.
• [31]Baird D, Clarke DM: Diabetes mellitus. In The Oxford Handbook of Rehabilitation Psychology. Edited by Kennedy P. New York: Oxford University Press; 2012:387-417.
• [32]Skinner T, Carey M, Cradock S, Dallosso H, Daly H, Davies M, Doherty Y, Heller S, Khunti K, Oliver L: Depressive symptoms in the first year from diagnosis of type 2 diabetes: results from the DESMOND trial. Diabet Med 2010, 27(8):965-967.
• [33]Morris N, MacLean C, Chew L, Littenberg B: The single item literacy screener: evaluation of a brief instrument to identify limited reading ability. BMC Fam Pract 2006, 7(1):21. BioMed Central Full Text
• [34]StataCorp: Stata Statistical Software: Release 10.0. College Station TX: StataCorp LP; 2007.
• [35]Lovibond PF, Lovibond SH: The structure of negative emotional states: comparison of the depression anxiety stress scales (DASS) with the beck depression and anxiety inventories. Behav Res Ther 1995, 33(3):335-343.
• [36]Antony MM, Bieling PJ, Cox BJ, Enns MW, Swinson RP: Psychometric properties of the 42-item and 21-item versions of the depression anxiety stress scales in clinical groups and a community sample. Psychol Assess 1998, 10(2):176-181.
• [37]Kissane DW, Wein S, Love A, Lee XQ, Kee PL, Clarke DM: The demoralization scale: a report of its development and preliminary validation. J Palliat Care 2004, 20(4):269-276.
• [38]Clarke DM, Kissane DW, Trauer T, Smith GC: Demoralization, anhedonia and grief in patients with severe physical illness. World Psychiatry 2005, 4(2):96-105.
• [39]Zimet GD, Dahlem NW, Zimet SG, Farley GK: The multidimensional scale of perceived social support. J Pers Assess 1988, 52(1):30-41.
• [40]Anderson RM, Fitzgerald JT, Gruppen LD, Funnell MM, Oh MS: The diabetes empowerment scale-short form (DES-SF). Diabetes Care 2003, 26(5):1641-1642.
• [41]Tudor-Locke C, Burkett L, Reis JP, Ainsworth BE, Macera CA, Wilson DK: How many days of pedometer monitoring predict weekly physical activity in adults? Prev Med 2005, 40(3):293-298.
• [42]Group E: EuroQol-a new facility for the measurement of health related quality of life. The EuroQol group. Health Policy 1990, 16:199-208.
• [43]Bosmans JE, Hermens ML, de Bruijne MC, van Hout HP, Terluin B, Bouter LM, Stalman WA, van Tulder MW: Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression. J Affect Disord 2008, 111(1):106-112.
• [44]Tracey TJ, Kokotovic AM: Factor structure of the working alliance inventory. Psychol Assess J Consult Clin Psychol 1989, 1(3):207.
• [45]Schulz KF, Altman DG, Moher D, for the CONSORT Group: CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340:c332.
• [46]Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG, for the CONSORT Group: CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340:c869.
• [47]World Health Organization: Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation. Geneva: World Health Organization; 2011.
• [48]Sturt JA, Whitlock S, Fox C, Hearnshaw H, Farmer AJ, Wakelin M, Eldridge S, Griffiths F, Dale J: Effects of the diabetes manual 1:1 structured education in primary care. Diabet Med 2008, 25(6):722-731.
• [49]Cooper Z, Doll HA, Hawker DM, Byrne S, Bonner G, Eeley E, O’Connor ME, Fairburn CG: Testing a new cognitive behavioural treatment for obesity: a randomized controlled trial with three-year follow-up. Behav Res Ther 2010, 48(8):706-713.
• [50]Henry JD, Crawford JR: The short-form version of the depression anxiety stress scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br J Clin Psychol 2005, 44(Pt 2):227-239.